Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ear Neoplasms × Ringer's Lactate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hemorrhage 2 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Peritoneal Neoplasm 1 Postoperative Complications 1 Neoplasm Metastasis 1 Ischemia 1 Hearing Loss 1 Fluid and Electrolyte Imbalance 1 Ear Neoplasms 1 Diverticulitis 1 Crohn Disease 1 Colonic Polyps 1 Colonic Neoplasms 1 Colitis, Ulcerative 1 Blood Loss, Surgical 1

Interventions

Saline Solution 1 Ringer's Lactate 1 Remifentanil 1 Ofloxacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡